
Corporate ActionApr 29, 2026, 07:02 AM
NTLA Prices Public Offering of 16.7M Shares at $10.75, Raising $180M
AI Summary
Intellia Therapeutics, Inc. announced the pricing of an underwritten public offering of 16,744,187 shares of its common stock at $10.75 per share. The offering is expected to generate approximately $180 million in gross proceeds for the company, before deducting underwriting discounts and expenses. Intellia has also granted underwriters a 30-day option to purchase up to an additional 2,511,628 shares.
Key Highlights
- Priced underwritten public offering of 16,744,187 common shares.
- Public offering price set at $10.75 per share.
- Expected gross proceeds of approximately $180 million.
- Underwriters granted 30-day option for up to 2,511,628 additional shares.
- All securities in the offering are being sold by Intellia.